Physician profile
Sameer Sadruddin Ali
NPI 1972267342
$2,423.87
in general payments reported to CMS, 2019-2025
26 companies · $606 in 2025
The $606 reported for 2025 was more than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $568 · 2023: $869 · 2024: $380 · 2025: $606.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,856.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,855.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $420.83 | 2023-2025 | |
| Merck Sharp & Dohme LLC | $271.51 | 2022-2025 | Verquvo |
| Astrazeneca Pharmaceuticals Lp | $259.21 | 2022-2025 | Farxiga, Wainua |
| Amgen INC. | $210.95 | 2022-2025 | Repatha, Repatha |
| Pfizer INC. | $187.99 | 2022-2025 | |
| E.R. Squibb & Sons, L.L.C. | $168.25 | 2022-2025 | Opdivo, Camzyos |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $116.29 | 2023-2025 | Lifevest |
| Boston Scientific Corporation | $104.82 | 2025 | Watchman Access System |
| Lexicon Pharmaceuticals, INC. | $89.35 | 2023-2024 | Inpefa |
| Janssen Pharmaceuticals, INC | $83.88 | 2022-2024 | Xarelto |
| Edwards Lifesciences Corporation | $63.93 | 2022-2023 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Baxter Healthcare | $59.21 | 2023 | Hillrom - Cardiac Ambulatory Monitor |
| Esperion Therapeutics, INC. | $51.58 | 2022-2025 | Nexletol |
| Novo Nordisk INC | $49.92 | 2023-2025 | Ozempic, Rybelsus, Wegovy |
| Kiniksa Pharmaceuticals, Ltd. | $43.24 | 2023 | Arcalyst |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $37.78 | 2023-2024 | |
| Lantheus Medical Imaging, INC. | $33.53 | 2023 | Definity |
| Scpharmaceuticals INC. | $22.86 | 2023 | |
| Abiomed | $21.92 | 2024 | Impella |
| Biotronik INC. | $20.84 | 2025 | |
| Inspire Medical Systems, INC. | $19.89 | 2025 | Inspire |
| Bayer Healthcare Pharmaceuticals INC. | $18.99 | 2022 | |
| Kiniksa Pharmaceuticals International, Plc | $18.82 | 2024 | Arcalyst |
| Heartflow, INC. | $17.85 | 2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.84 | 2023 | Jardiance |
| Alnylam Pharmaceuticals INC. | $14.59 | 2025 | Amvuttra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sameer Ali listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.